NCT00110981View on ClinicalTrials.gov

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

PHASE4CompletedINTERVENTIONAL

Enrollment

86

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

March 31, 2006

Conditions

Psoriasis

Interventions

DEVICE

NB-UVB

Three times a week (TIW) for 12 weeks

DRUG

Etanerept

50 mg subcutaneously twice weekly (SC BIW) for 12 weeks

DRUG

Etanercept

50 mg subcutaneously twice weekly (SC BIW) for 12 weeks

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Amgen

INDUSTRY